A mono center, open-label, randomized study examining the effects of intra-dermal vs. subcutaneous application of regular human insulin or rapid-acting insulin analogue on postprandial glycemic excursions in patients with type 1 diabetes.
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2011
At a glance
- Drugs Insulin (Primary) ; Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 10 Aug 2011 New trial record